Aurinia Pharmaceuticals
AUPH
AUPH
179 hedge funds and large institutions have $281M invested in Aurinia Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 47 increasing their positions, 63 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less call options, than puts
Call options by funds: $8.72M | Put options by funds: $13.4M
44% less capital invested
Capital invested by funds: $498M → $281M (-$217M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
179
Holding in Top 10
–
Calls
$8.72M
Puts
$13.4M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$10.2M | |
| 3 | +$5M | |
| 4 |
6CM
683 Capital Management
New York
|
+$2.68M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$2M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$4.71M | |
| 3 | -$4.46M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.06M |
| 5 |
Jane Street
New York
|
-$3.21M |